Leuprorelin
- CAS No.
- 53714-56-0
- Chemical Name:
- Leuprorelin
- Synonyms
- LEUPROLIDE;Lucrin;Leuplin;a-43818;Carcinil;Enantone;nghormone;LEUPRORELIN;LEUPROPELIN;Leuprorelinum
- CBNumber:
- CB8398455
- Molecular Formula:
- C59H84N16O12
- Molecular Weight:
- 1209.4
- MOL File:
- 53714-56-0.mol
- Modify Date:
- 2024/10/25 16:21:11
alpha | D25 -31.7° (c = 1 in 1% acetic acid) |
---|---|
Density | 1.44±0.1 g/cm3(Predicted) |
storage temp. | −20°C |
solubility | DMSO (Slightly), Methanol (Slightly), Water (Slightly) |
pka | 9.82±0.15(Predicted) |
Water Solubility | Soluble in water at 1mg/ml |
Stability | Hygroscopic |
InChIKey | RGLRXNKKBLIBQS-VAZQWRJQNA-N |
CAS DataBase Reference | 53714-56-0(CAS DataBase Reference) |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS08 |
---|---|
Signal word | Danger |
Hazard statements | H360 |
Precautionary statements | P201-P280-P308+P313 |
Safety Statements | 22-24/25 |
WGK Germany | 2 |
RTECS | OH6390000 |
Hazardous Substances Data | 53714-56-0(Hazardous Substances Data) |
Leuprorelin Chemical Properties,Uses,Production
Chemical Properties
Hygroscopic, white or almost white powder.
Uses
Gonadotropin releasing hormone (gonadorelin) analogue; treatment of prostate cancer.
Indications
Leuprolide is a potent LH-RH agonist for the first several days to a few weeks after initiation of therapy, and therefore, it initially stimulates testicular and ovarian steroidogenesis. Because of this initial stimulation of testosterone production, it is recommended that patients with prostatic cancer be treated concurrently with leuprolide and the antiandrogen flutamide (discussed earlier). Leuprolide is generally well tolerated, with hot flashes being the most common side effect.
Definition
ChEBI: An oligopeptide comprising pyroglutamyl, histidyl, tryptophyl, seryl, tyrosyl, D-leucyl, leucyl, arginyl, and N-ethylprolinamide residues joined in sequence. Leuprorelin is a synthetic nonapeptide analogue of gonadotropin-releasi g hormone, and is used as a subcutaneous hydrogel implant (particularly as the acetate salt) for the treatment of prostate cancer and for the suppression of gonadal sex hormone production in children with central precocious puberty.
Synthesis
The synthesis process of Leuprorelin includes the following steps:
(1) Fmoc-Pro-HMPB-AM resin is obtained from Fmoc-Pro-OH and HMPB-AM resin with a substitution degree of 0.2mmol/g~1.2mmol/g as starting materials;
(2) The Fmoc-Pro-HMPB-AM resin was coupled one by one by Fmoc/tBu solid phase method to connect amino acids with protective groups in sequence, and the side chain fully protected leuprolide precursor peptide-HMPB-AM was synthesized Resin;
(3) Cut the side chain fully protected leuprolide precursor peptide-HMPB-AM resin to obtain the side chain fully protected leuprolide precursor peptide;
(4) Fully protected side chain leuprolide precursor peptide undergoes ethylamination to obtain side chain fully protected leuprolide;
(5) Leuprolide is fully protected on the side chain by removing the side chain protecting group to obtain the crude leuprolide peptide;
(6) The crude leuprorelin peptide is separated and purified by a high-pressure liquid phase column and lyophilized to obtain the leuprolide refined peptide.
Leuprorelin Preparation Products And Raw materials
Raw materials
1of5
chevron_rightPreparation Products
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Jigs Chemical ltd | +919099003427 | Gujarat, India | 239 | 58 | Inquiry |
Shilpa Medicare Limited (SML) | +91-8532238704 +91-9320649838 | Karnataka, India | 61 | 58 | Inquiry |
Ralington Pharma | +91-7948911722 +91-9687771722 | Gujarat, India | 1350 | 58 | Inquiry |
AKASH PHARMA EXPORTS | +91-9388123451 +91-9846039283 | Kerela, India | 470 | 58 | Inquiry |
Ranbaxy Laboratories Limited | (+91 22) 4324 4324 | New Delhi, India | 76 | 58 | Inquiry |
HEMMO PHARMACEUTICALS PVT. LTD. | +91-22-69026200 | New Delhi, India | 6 | 58 | Inquiry |
CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6257 | 58 | Inquiry |
SynZeal Research Pvt Ltd | +1 226-802-2078 | Gujarat, India | 6514 | 58 | Inquiry |
Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6739 | 58 | Inquiry |
OCEAN TRADING CORPORATION | +91(22) 24921669 | New Delhi, India | 6202 | 58 | Inquiry |
Related articles
- Leuprorelin: Pharmacodynamic Properties, Dosage and Administration
- Leuprorelin, a gonadotrophin-releasing hormone analogue, reduces sex hormone levels for treating conditions like prostatic can....
- Sep 30,2024
- Leuprorelin: pharmacokinetics, clinical applications and safety
- Leuprorelin is a parenterally administered medication with high bioavailability, used for various clinical applications and as....
- Oct 7,2023
- Instructions for Leuprolide
- Leuprorelin/Leuprolideacetate (LA) is a highly active analogue (LHRH-A, GnRHA) of luteinizing hormone releasing hormone (LHRH,....
- Sep 25,2020
53714-56-0(Leuprorelin)Related Search:
1of4
chevron_right